NeuroPace Inc
NPCE· Nasdaq
NPCENeuroPace Inc
Filed Aug 12, 2021 · 10-Q · 43 days after period end · 0001528287-21-000011
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $12.63M | $7.64M |
| Net Income | -$8.49M | -$8.79M |
| EPS Diluted | -$0.48 | -$43.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NeuroPace Inc · CIK 1528287 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end
